End Allergies Together Research Funding

A business and finance graduate based in Greenwich, Connecticut, Marc Wolpers dedicates his life to his family and fitness. Marc Wolpers and his children participated in the benefits road race, Run To EAT, for the End Allergies Together (EAT) organization.

Established in 2015, EAT is a nonprofit organization dedicated to promoting medical and scientific research to accelerate treatments and cures of food allergies. EAT funds only the most promising research while keeping a diversified portfolio to increase the probabilities of breakthroughs. The EAT funding happens in two ways. EAT advises significant donors interested in making a directed donation, and the medical advisory board follows an objective grant process to allocate funding for research studies.

EAT focuses on rewarding promising research toward clinical testing and accelerating both shorter-term and longer-term goals for the second type of funding. The funded studies are categorized in some relevant aspects to food allergies, such as biomarkers, microbiome, oral immunotherapy, and eosinophilic esophagitis. Biomarkers, for instance, are substances able to detect or confirm a condition or disease and EAT grants funds to research focused on developing better biomarkers so that other types of diagnoses are not as necessary, such as food challenges often expensive and dreaded by the individual.